Yiming Luo, MD

Howard J. Worman, M.D. is Professor of Medicine and Pathology and Cell Biology at Columbia University’s College of Physicians and Surgeons. Dr. Worman received his BA from Cornell University and MD from the University of Chicago Pritzker School of Medicine. He did clinical training in internal medicine at New York Hospital-Cornell Medical Center and postdoctoral research training in cell biology at Rockefeller University. He then obtained clinical training in liver diseases at the Mount Sinai Medical Center. Dr. Worman is internationally recognized for his research in cell biology and hepatology. His laboratory research is focused on primarily on the cell biology of rare genetic diseases. These include different types of muscular dystrophy, cardiomyopathy, lipodystrophy and premature aging syndromes (progeria) . He also does research on non-alcoholic fatty liver disease and on the characterization of antibodies in autoimmune liver diseases. His clinical practice is primarily devoted to consultation in liver diseases. Dr. Worman is an author on over 200 scientific publications. In 1998, he was elected to membership in the American Society for Clinical Investigator and, in 2010, to the Association of American Physicians. He has served on the Editorial Boards of Hepatology, Gastroenterology, Molecular Biology of the Cell and Journal of Autoimmunity and as a Section Editor of BMC Cell Biology. Dr. Worman is also author of the popular Liver Disorders and Hepatitis Sourcebook (McGraw-Hill, 2006). Email: hjw14@cumc.columbia.edu

Dr. Tamna Wangjam is a specialist in Hematology and Oncology, focusing on Blood and Marrow Stem Cell Transplantation. He serves as an Assistant Professor of Medicine at Columbia University Medical Center and is affiliated with NewYork-Presbyterian Columbia University Irving Medical Center. Dr. Wangjam completed his medical education at Delhi University and furthered his training with a fellowship at the University of Texas Health San Antonio MD Anderson Cancer Center. His extensive residency experience includes programs at Johns Hopkins University and Stanford University School of Medicine. Generated from the website

Dr. Thomas F.X. O'Donnell is a vascular surgeon in the Aortic Center at New York Presbyterian/Columbia University Irving Medical Center. He treats the full spectrum of vascular disease including advanced open and minimally invasive techniques for treating cerebrovascular, peripheral, and mesenteric disease with a special focus on complex aortic pathologies. After graduating the University of Notre Dame and subsequently Weill Cornell Medical College, Dr. O'Donnell completed his surgery residency at Massachusetts General Hospital, and a fellowship in vascular and endovascular surgery at Beth Israel Deaconess Medical Center. He spent two years as a Harvard-Longwood T32 Research fellow and completed the Harvard T.H. Chan School of Public Health's Program of Clinical Effectiveness. A surgeon-scientist, Dr. O'Donnell specializes in clinical outcomes research utilizing large databases. He has published over 50 manuscripts in peer-reviewed journals, two book chapters, and is a reviewer for several surgical journals. His research focuses on the optimal treatment strategies for aortic aneurysms and dissections.